In our study, we also analysis CDHR5 expression in pancreatic adenosquamous carcinoma in the TMA, outcomes suggested that CDHR5 was down‐regulated in this pancreatic cancer subtype, which was different from that in PDAC (data not shown). This evidence concerns the gene CDHR5 and pancreatic adenosquamous carcinoma.